We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Ribavirin Pregnancy Registry (RPR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00114712
Recruitment Status : Recruiting
First Posted : June 17, 2005
Last Update Posted : March 16, 2018
Aurobindo Pharma
Genentech, Inc.
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals USA
Zydus Pharmaceuticals USA, Inc.
Kadmon Pharmaceuticals
Information provided by (Responsible Party):
INC Research

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2024
  Estimated Study Completion Date : December 2025